✦ LIBER ✦

Evaluation and comparison of two new prostate carcinoma markers: Free-prostate specific antigen and prostate specific membrane antigen

✍ Scribed by Gerald P. Murphy; Robert J. Barren; Sheila J. Erickson; Victoria A. Bowes; Robert L. Wolfert; Georg Bartsch; Helmut Klocker; Joseph Pointner; A. Reissigl; David G. McLeod; Thomas Douglas; Ted Morgan; Gerald M. Kenny; Haakon Ragde; Alton L. Boynton; Eric H. Holmes

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 816 KB
Volume: 78
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19960815)78:4<809::aid-cncr18>3.0.co;2-z

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

Two new prostate cancer markers, free-prostate specific antigen (f-PSA) and prostate specific membrane antigen (PSMA) were recently introduced. This report summarizes a prospective two-year multicenter test of their diagnostic or prognostic capabilities. Total PSA was also measured.

📜 SIMILAR VOLUMES

Comparison of serum prostate specific me

Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients

✍ Thomas H. Douglas; Ted O. Morgan; David G. McLeod; Judd W. Moul; Gerald P. Murph 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

ated with higher pathologic stage and grade in patients undergoing radical prostatectomy (RP). In earlier studies, serum prostate specific membrane antigen (PSMA)

Prostate-specific membrane antigen

✍ Fair, William R.; Israeli, Ron S.; Heston, Warren D.W. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 545 KB

## Background: In an effort to discover new prostate-specific antigens (psas) to enhance our understanding of the functions and behavior of the prostate and the complex processes involved in prostate tumor progression, the structure and function of the psm antigen has been elucidated. ## Methods:

Prostate specific antigen and prostate s

Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management

✍ Mitchell C. Benson; Carl A. Olsson 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 642 KB

Correlation of prostate-specific acid ph

Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma

✍ M. Elizabeth Hammond; William T. Sause; Karen L. Martz; Miljenko V. Pilepich; Su 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 610 KB

Radiotherapy for localized prostate carc

Radiotherapy for localized prostate carcinoma : The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen

✍ Juanita M. Crook; Yasir A. Bahadur; R. Gregory Bociek; Gad A. Perry; Susan J. Ro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Background: The objective of this study was to correlate the failure pattern of localized prostate carcinoma after radiotherapy (rt) with pretreatment (pretx) psa and post-rt nadir psa, using systematic biopsies and serum psa in the assessment of outcome. ## Methods: From january 1990 to febru

Anti–prostate-Specific membrane antigen-

Anti–prostate-Specific membrane antigen-based radioimmunotherapy for prostate cancer

✍ Scott T. Tagawa; Himisha Beltran; Shankar Vallabhajosula; Stanley J. Goldsmith; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

## Abstract Despite recent advances, advanced prostate cancer is suboptimally responsive to current chemotherapeutic agents. Radiolabeled monoclonal antibody therapy that targets prostate‐specific membrane antigen (PSMA) shows promise and is an area of active investigation. J591 is a deimmunized Ig